查詢結果分析
來源資料
頁籤選單縮合
題 名 | 益生菌於肺部疾病患者之臨床應用=Clinical Application of Probiotics in Patients with Lung Disease |
---|---|
作 者 | 蔡盈億; 林佩姿; | 書刊名 | 藥學雜誌 |
卷 期 | 34:3=136 2018.09[民107.09] |
頁 次 | 頁31-35 |
分類號 | 369.35 |
關鍵詞 | 益生菌; 呼吸道感染; 肺部疾病; Probiotics; Respiratory infections; Lung disease; |
語 文 | 中文(Chinese) |
中文摘要 | 益生菌的定義為「在適當的用量下,能夠帶給宿主好處的活微生物」,其主要生 理機轉為增強黏膜的屏障功能、促進宿主細胞製造益於人體的物質、調節宿主的局部 免疫系統,是近年來備受注目的治療與預防選擇。益生菌在氣喘的治療與預防方面, 能夠調節宿主的局部免疫系統,可用來預防氣喘的發生;而應用於呼吸道感染,益 生菌能降低加護病房 VAP (ventilator associated pneumonia) 的發生率。有關在 COPD (chronic obstructive pulmonary disease) 的應用上,病毒感染也可能引起 COPD 急性發 作,NK cell (natural killer cell) 的活化在病毒感染的早期免疫反應佔了重要的角色,活 化後的 NK cell 能夠製造大量的 IFN-Ƴ (interferon-Ƴ) 來控制病毒的感染情形,而每日 服用益生菌 Lactobacillus casei Shirota 能夠增加吸菸患者的 NK cell 活性。然而,目前 益生菌在於肺部疾病臨床的使用上,尚無法取代正規的藥物治療,仍屬於輔助療法。 |
英文摘要 | Probiotics are characterized as “live organisms, which when applied in adequate amounts confer a health benefit to the host.” The main mechanisms are to enhance the barrier function of the mucosa, to promote the host cells to produce substances that are beneficial to the human body, and to regulate the local immune system of the host. In the treatment and prevention of asthma, probiotics can regulate the host of the local immune system to prevent asthma in animal models. Also, probiotcs are suggested associated with a reduction in the incidence of VAP. In the application of COPD, the virus infection may cause acute exacerbation of COPD, and NK cell activation in the early virus infection plays an important role in the activated NK cell. Daily use of probiotics Lactobacillus casei Shirota can increase the NK cell activity of smoking patients. However, the clinical use of probiotics in treating lung disease remains as adjunctive therapy now. |
本系統中英文摘要資訊取自各篇刊載內容。